This Edition
ARTICLE | Clinical News
ARRY-543: Phase Ib/II start
WIR Staff
November 12, 2007 8:00 AM UTC
Next year, ARRY will begin a Phase Ib/II trial of ARRY-543 in combination with capecitabine. ...